z-logo
open-access-imgOpen Access
Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression
Author(s) -
Kol Jia Yong,
Daniela S. Daniela Sanchez Bassères,
Robert S. Welner,
Wen Cai Zhang,
Henry Yang,
Benedict Yan,
Meritxell Alberich-Jordà,
Junyan Zhang,
Lorena Lôbo Figueiredo-Pontes,
Chiara Battelli,
Christopher J. Hetherington,
Min Ye,
Hong Zhang,
Giorgia Maroni,
Karen O’Brien,
Maria Cristina Magli,
Alain Borczuk,
Lyuba Varticovski,
Olivier Kocher,
Pu Zhang,
Young-Choon Moon,
Nadiya Sydorenko,
Liangxian Cao,
Thomas W. Davis,
Bhavin Thakkar,
Ross A. Soo,
Atsushi Iwama,
Bing Lim,
Balázs Halmos,
Doneuberg,
Daniel G. Tenen,
Elena Levantini
Publication year - 2016
Publication title -
science translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.819
H-Index - 216
eISSN - 1946-6242
pISSN - 1946-6234
DOI - 10.1126/scitranslmed.aad6066
Subject(s) - bmi1 , cancer research , lung , medicine , adenocarcinoma , lung cancer , oncology , biology , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom